Calumet Specialty Prods Analyst Ratings
Calumet Specialty Prods Analyst Ratings
While ratings are subjective and will change, the latest Calumet Specialty Prods (CLMT) rating was a maintained with a price target of $19.00 to $17.00. The current price Calumet Specialty Prods (CLMT) is trading at is $14.01, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/31/2023 | 21.34% | Goldman Sachs | $19 → $17 | Maintains | Buy |
| 08/07/2023 | 78.44% | HC Wainwright & Co. | → $25 | Reiterates | Buy → Buy |
| 06/13/2023 | 35.62% | Goldman Sachs | $20 → $19 | Maintains | Buy |
| 05/15/2023 | 39.19% | UBS | $18.5 → $19.5 | Maintains | Neutral |
| 05/08/2023 | 92.72% | Wells Fargo | $29 → $27 | Maintains | Overweight |
| 05/08/2023 | 64.17% | TD Cowen | $21 → $23 | Maintains | Outperform |
| 01/25/2023 | 78.44% | HC Wainwright & Co. | $28 → $25 | Maintains | Buy |
| 12/14/2022 | 12.06% | UBS | → $15.7 | Initiates Coverage On | → Neutral |
| 08/18/2022 | 64.17% | Goldman Sachs | $14 → $23 | Upgrades | Neutral → Buy |
| 06/28/2022 | 42.76% | Cowen & Co. | $18 → $20 | Maintains | Outperform |
| 05/09/2022 | 42.76% | Cowen & Co. | $18 → $20 | Maintains | Outperform |
| 04/21/2022 | 107% | Wells Fargo | $27 → $29 | Maintains | Overweight |
| 02/28/2022 | 99.86% | HC Wainwright & Co. | $19 → $28 | Maintains | Buy |
| 11/23/2021 | 114.13% | Wolfe Research | → $30 | Upgrades | Peer Perform → Outperform |
| 11/23/2021 | 64.17% | Cowen & Co. | $12 → $23 | Upgrades | Market Perform → Outperform |
| 10/15/2021 | -21.48% | Goldman Sachs | $6 → $11 | Maintains | Neutral |
| 10/08/2021 | -21.48% | Wells Fargo | $8 → $11 | Maintains | Overweight |
| 10/04/2021 | 35.62% | HC Wainwright & Co. | → $19 | Initiates Coverage On | → Buy |
| 03/24/2021 | -42.9% | Wells Fargo | → $8 | Upgrades | Equal-Weight → Overweight |
| 12/15/2020 | -71.45% | Wells Fargo | → $4 | Downgrades | Overweight → Equal-Weight |
| 03/27/2020 | -92.86% | Goldman Sachs | $2 → $1 | Maintains | Neutral |
| 02/11/2020 | — | Raymond James | Upgrades | Underperform → Market Perform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年10月31日 | 21.34% | 高盛 | $19→$17 | 維護 | 買 |
| 08/07/2023 | 78.44% | HC Wainwright公司 | →$25 | 重申 | 購買→購買 |
| 2023/06/13 | 35.62% | 高盛 | $20→$19 | 維護 | 買 |
| 2023年05月15日 | 39.19% | 瑞銀集團 | $18.5→$19.5 | 維護 | 中性 |
| 05/08/2023 | 92.72% | 富國銀行 | $29→$27 | 維護 | 超重 |
| 05/08/2023 | 64.17% | TD Cowen | $21→$23 | 維護 | 跑贏大盤 |
| 2023年1月25日 | 78.44% | HC Wainwright公司 | $28→$25 | 維護 | 買 |
| 2022年12月14日 | 12.06% | 瑞銀集團 | →$15.7 | 開始承保 | →中性 |
| 2022/08/18 | 64.17% | 高盛 | $14→$23 | 升級 | 中性→購買 |
| 2022/06/28 | 42.76% | 考恩公司 | $18→$20 | 維護 | 跑贏大盤 |
| 05/09/2022 | 42.76% | 考恩公司 | $18→$20 | 維護 | 跑贏大盤 |
| 04/21/2022 | 107% | 富國銀行 | $27→$29 | 維護 | 超重 |
| 02/28/2022 | 99.86% | HC Wainwright公司 | $19→$28 | 維護 | 買 |
| 2021年11月23日 | 114.13% | 沃爾夫研究 | →$30 | 升級 | 同業表現優於→ |
| 2021年11月23日 | 64.17% | 考恩公司 | $12→$23 | 升級 | 市場表現優於→ |
| 2021年10月15日 | -21.48% | 高盛 | $6→$11 | 維護 | 中性 |
| 10/08/2021 | -21.48% | 富國銀行 | $8→$11 | 維護 | 超重 |
| 10/04/2021 | 35.62% | HC Wainwright公司 | →$19 | 開始承保 | →購買 |
| 03/24/2021 | -42.9% | 富國銀行 | →$8 | 升級 | 等重→超重 |
| 12/15/2020 | -71.45% | 富國銀行 | →$4 | 評級下調 | 超重→等重 |
| 03/27/2020 | -92.86% | 高盛 | $2→$1 | 維護 | 中性 |
| 02/11/2020 | - | 雷蒙德·詹姆斯 | 升級 | 表現遜於→市場表現 |
What is the target price for Calumet Specialty Prods (CLMT)?
Calumet特種產品(CLMT)的目標價格是多少？
The latest price target for Calumet Specialty Prods (NASDAQ: CLMT) was reported by Goldman Sachs on October 31, 2023. The analyst firm set a price target for $17.00 expecting CLMT to rise to within 12 months (a possible 21.34% upside). 8 analyst firms have reported ratings in the last year.
高盛於2023年10月31日報告了Calumet Specialty Prods(納斯達克：CLMT)的最新目標價。這家分析公司將目標價定為17.00美元，預計CLMT將在12個月內上漲至21.34%。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for Calumet Specialty Prods (CLMT)?
Calumet Specialty Prods(CLMT)的最新分析師評級是什麼？
The latest analyst rating for Calumet Specialty Prods (NASDAQ: CLMT) was provided by Goldman Sachs, and Calumet Specialty Prods maintained their buy rating.
納斯達克的最新分析師評級由高盛提供，Calumet Specialty Prods維持買入評級。
When is the next analyst rating going to be posted or updated for Calumet Specialty Prods (CLMT)?
Calumet Specialty Prods(CLMT)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Calumet Specialty Prods, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Calumet Specialty Prods was filed on October 31, 2023 so you should expect the next rating to be made available sometime around October 31, 2024.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公共財務報表，與Calumet Specialty Prods的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Calumet Specialty Prods的上一次評級是在2023年10月31日提交的，因此您應該預計下一次評級將在2024年10月31日左右提供。
Is the Analyst Rating Calumet Specialty Prods (CLMT) correct?
分析師評級Calumet Specialty Prods(CLMT)正確嗎？
While ratings are subjective and will change, the latest Calumet Specialty Prods (CLMT) rating was a maintained with a price target of $19.00 to $17.00. The current price Calumet Specialty Prods (CLMT) is trading at is $14.01, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Calumet Specialty Prods(CLMT)評級保持不變，目標價在19.00美元至17.00美元之間。Calumet Specialty Prods(CLMT)目前的交易價格為14.01美元，超出了分析師的預測範圍。
